Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present relates to a specific share transaction:
- Share Purchase Price: 1470.26 pence per share.
- Transaction Date: July 11, 2012.
- Shares Acquired: 23,386 ordinary shares.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses an increase in shareholding by a connected person.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. The transaction was executed following the re-investment of the dividend paid to shareholders on July 5, 2012.
Investor Verification Points
- Verify the total shareholding of Mrs. K Thomson (Connected Person) post-transaction.
- Confirm the dividend reinvestment plan details for the July 5, 2012 payment.
- Note that this filing does not contain quarterly or annual financial performance data.